How Seth was paid
$1.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Total |
|---|---|---|---|
| Sandesh SethChairman and Chief Executive Officer | $762,320 | $425,000 | $1,187,320 |
| Steve O’LoughlinFormer Chief Financial Officer (through February 2026) | $445,536 | $100,901 | $546,437 |
What changed and why
- $1.2M2025 CEO total compensation was $1,187,320, compared with $1,173,200 in 2024.
- $425K2025 CEO bonus of $425,000 related to prior-year performance and was determined and paid in 2025.
- 50%50% of CEO annual base salary is the target for his performance bonus.
- The company said it used no financial performance measures to link NEO compensation to company performance in 2025.
- Seth and O’Loughlin consented to cancellation of their outstanding stock options in 2025 and held none at year-end.
- In September 2026, Seth received options for 1,130,400 shares and RSU grants totaling 1,762,874 shares.
Other Actinium Pharmaceuticals proxy statements
- 2025 proxy statement
Sandesh Seth paid $1.2M (-75% on the year).
Filed Nov 05, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.